FysioDanmark Ishøj ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  3.6% 5.0% 3.5% 3.0% 4.0%  
Credit score (0-100)  53 44 52 57 49  
Credit rating  BBB BBB BBB BBB BBB  
Credit limit (kDKK)  -0.0 -0.0 -0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  5,558 5,449 6,478 7,657 7,747  
EBITDA  626 -131 716 1,308 1,040  
EBIT  419 -366 468 1,094 870  
Pre-tax profit (PTP)  238.8 -756.9 232.9 853.8 400.8  
Net earnings  175.5 -700.6 156.3 640.9 301.9  
Pre-tax profit without non-rec. items  239 -757 233 854 401  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  3,769 3,701 3,552 3,449 3,279  
Shareholders equity total  -1,641 -2,342 -2,185 -1,544 -1,242  
Interest-bearing liabilities  5,109 5,115 5,060 4,062 3,320  
Balance sheet total (assets)  4,389 4,416 4,132 4,102 3,905  

Net Debt  5,083 5,050 5,014 4,058 3,320  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  5,558 5,449 6,478 7,657 7,747  
Gross profit growth  48.9% -2.0% 18.9% 18.2% 1.2%  
Employees  12 14 14 15 15  
Employee growth %  100.0% 16.7% 0.0% 7.1% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  4,389 4,416 4,132 4,102 3,905  
Balance sheet change%  -0.8% 0.6% -6.4% -0.7% -4.8%  
Added value  625.9 -131.1 715.9 1,342.6 1,039.5  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -222 -303 -397 -317 -340  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  2.0 -1.0 1.0 2.0 3.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  7.5% -6.7% 7.2% 14.3% 11.2%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  6.8% -2.4% 7.2% 18.3% 16.8%  
ROI %  7.7% -10.8% 8.5% 23.0% 25.6%  
ROE %  4.0% -15.9% 3.7% 15.6% 7.5%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  -27.2% -34.7% -34.6% -27.3% -24.1%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  812.1% -3,853.3% 700.4% 310.3% 319.4%  
Gearing %  -311.3% -218.5% -231.6% -263.0% -267.2%  
Net interest  0 0 0 0 0  
Financing costs %  3.4% 3.5% 4.6% 5.3% 14.7%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.1 0.1 0.1 0.2 0.3  
Current Ratio  0.1 0.1 0.1 0.2 0.3  
Cash and cash equivalent  25.3 65.7 46.1 3.8 0.3  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -3,417.1 -3,919.3 -3,771.8 -3,166.5 -1,597.7  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  52 -9 51 90 69  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  52 -9 51 87 69  
EBIT / employee  35 -26 33 73 58  
Net earnings / employee  15 -50 11 43 20